IND: induction and LFT: liver function tests.
including seizures, tremors, facial palsy, hemiparesis, peripheral neuropathy and motor weakness. bSeptic shock including hypotension and/or requiring intubation. cProlonged partial thromboplastin time or hypofibrinogenemia.
dAspartate aminotransferase, alanine aminotransferase, or alkaline phosphatase >1.5 times the normal value, or total bilirubin >1.5 times the normal value.
The 3-year EFS rates for pegaspargase and native ASNase patients were 85% and 78%, respectively (NS) (Figure 14.19).
There were no differences in the incidence or the types of toxicities in between the two groups of patients (Table 14.26). No toxicity-related deaths were seen in either group.
It was concluded that patients treated with pegaspargase had more rapid clearance of lymphoblasts from the bone marrow on days 7 and 14 and more prolonged asparaginase activity than those treated with native asparaginase.
Was this article helpful?
This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.